NYLIM
IPSC icon

New York Life Investment Management’s Century Therapeutics IPSC Stock Holding History

New York Life Investment Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-99,912
Closed -$332K – 1430
2023
Q4 		$332K Sell
99,912
-2,694
-3% -$4.91K ﹤0.01% 1153
2023
Q3 		$205K Sell
102,606
-16,165
-14% -$43K ﹤0.01% 1270
2023
Q2 		$375K Sell
118,771
-15,058
-11% -$48.5K ﹤0.01% 1089
2023
Q1 		$464K Buy
+133,829
New +$588K 0.01% 1112

Other funds holding IPSC

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

New York Life Investment Management's IPSC Position: Q1 2024 in Review

New York Life Investment Management sold out of Century Therapeutics (IPSC) in Q1 2024, closing a stake of 99,912 shares — an estimated $332K sold.

New York Life Investment Management first reported a position in IPSC in Q1 2023 and held it in 4 quarters. The position peaked at $464K in Q1 2023. 67 funds tracked by Wall St. Rank hold IPSC as of Q1 2024.

  • New York Life Investment Management reported no remaining Century Therapeutics position as of Q1 2024 after selling out during the quarter.
  • New York Life Investment Management sold 99,912 Century Therapeutics shares in Q1 2024, an estimated $332K.
  • New York Life Investment Management first reported a position in Century Therapeutics in Q1 2023 and held it in 4 quarters.
  • New York Life Investment Management's Century Therapeutics position peaked at $464K in Q1 2023.
  • 67 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.